A Study to Assess the Efficacy and Safety of Nusinersen (ISIS 396443) in Participants With Later-onset Spinal Muscular Atrophy (SMA)
Clinical trial NCT02292537 · COMPLETED
Trial details
- NCT number
- NCT02292537
- Sponsor
- Biogen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-24
- Primary completion
- 2017-02-20
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.